Results

Total Results: 1,027 records

Showing results for "drug".

1021. Screening for Obesity in Children and Adolescents: USPSTF Recommendations Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/PdBbRgWKPMbHfeQeHkM242
      February 01, 2010 - clinical practice, obesity, screening ABBREVIATIONS USPSTF—US Preventive Services Task Force FDA—Food and Drug … Sibutramine, a centrally acting appe- tite suppressant, has been approved by the US Food and Drug Administra

1022. Archived: High Blood Pressure in Adults, Children, and Adolescents: Screening, 2003 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-adults-children-adolescents-screening-2003
      April 01, 2003 - sufficiently bothersome to interfere with adherence to the medication regimen—are common, but serious adverse drug … Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological

1023. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening
      August 08, 2005 - Peripheral arterial disease: epidemiology and drug therapy.

1024. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening-2005
      August 08, 2005 - Peripheral arterial disease: epidemiology and drug therapy.

1025. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
      June 26, 2018 - Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … [95% CI, 0.98-1.05]; I 2 = 0.0%; 13 RCTs [20,485 participants]) for any individual bisphosphonate drug … or race Fair KQ4b: Effectiveness of Pharmacotherapy by Subgroup Women 4 (varies by drug … Consistency unknown (single trial); precise No evidence of reporting bias Single trial for each drug … Abbreviations: BMD, bone mineral density; EPC, Evidence-based Practice Center; FDA, US Food and Drug

1026. Archived: Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review: Hepatitis C: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
      November 15, 2012 - Food and Drug Administration. … Approval of Victrelis (boceprevir) a direct acting antiviral drug (DAA) to treat hepatitis C virus (HCV … Food and Drug Administration. … Food and Drug Administration for boceprevir in antiviral-naive patients with cirrhosis at baseline. … Food and Drug Administration for telaprevir.

1027. Screening for Syphilis: A Brief Update (pdf file)
      www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
      July 01, 2004 - Penicillin G is the recommended drug for treatment of syphilis at all stages. … Harms include drug-related effects including anaphylaxis from penicillin allergy.